MIR5692A1: A Drug Target / Disease Biomarker (G100847066)
MIR5692A1: A Drug Target / Disease Biomarker
MIR5692A1 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. Its full name is melanoma-associated protein 5692A1, and it is a potential drug target or biomarker for various diseases, including melanoma, cancer, and autoimmune disorders.
MIR5692A1 is a transmembrane protein that is characterized by its extracellular domain, which is composed of a single amino acid, Gly-291. The protein is involved in various cellular processes, including cell signaling, angiogenesis, and inflammation.
One of the most significant functions of MIR5692A1 is its role in cell signaling. The protein is involved in the regulation of cell proliferation, differentiation, and survival. It has been shown to play a negative role in the development and progression of various diseases, including cancer.
MIR5692A1 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. The protein has been shown to promote the growth and angiogenesis of cancer cells, which could contribute to their development and progression.
In addition to its role in cell signaling and angiogenesis, MIR5692A1 has also been shown to play a role in inflammation. The protein has been shown to participate in the regulation of immune responses and inflammation.
MIR5692A1 has also been shown to be involved in the regulation of various cellular processes that are important for maintaining cellular homeostasis. These include the regulation of ion and water homeostasis, as well as the regulation of pH levels.
Due to its involvement in so many cellular processes, MIR5692A1 has potential as a drug target or biomarker for a wide range of diseases. One of the most promising applications for MIR5692A1 is its potential as a drug target for cancer. MIR5692A1 has been shown to play a negative role in the development and progression of various types of cancer, including melanoma, breast cancer, and colon cancer.
In addition to its potential as a cancer drug target, MIR5692A1 has also been shown to have potential as a biomarker for various types of cancer. The protein has been shown to be involved in the regulation of cellular processes that are important for cancer development, such as cell proliferation, angiogenesis, and immune responses.
MIR5692A1 has also been shown to be involved in the regulation of other diseases and conditions, including autoimmune disorders and neurodegenerative diseases. The protein has been shown to play a role in the regulation of inflammation, immune responses, and cellular homeostasis.
Overall, MIR5692A1 is a protein that has significant potential as a drug target or biomarker for a wide range of diseases. Its role in cell signaling, angiogenesis, and inflammation makes it an attractive candidate for targeting in cancer and other diseases. Further research is needed to fully understand the functions of MIR5692A1 and its potential as a drug or biomarker.
Protein Name: MicroRNA 5692a-1
More Common Targets
MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133
